Ongoing research has identified several medication groups that may increase dementia risk over time. The strongest evidence points to drugs with anticholinergic properties, but other classes have also been linked to cognitive decline.
This article is not meant to alarm you, but to inform you. If you or a loved one are taking any of these medications, it is important to have a conversation with your healthcare provider—not to stop medication abruptly, but to weigh the benefits and risks.
Anticholinergics Are the Primary Concern
Anticholinergic drugs block acetylcholine, a neurotransmitter essential for learning and memory. Long-term or high-dose use of these medications is consistently associated with an increased risk of dementia.
Common Anticholinergic Drugs
| Class | Examples | Common Uses |
|---|---|---|
| Overactive bladder medications | Oxybutynin, Tolterodine | Urinary urgency, incontinence |
| Antidepressants | Amitriptyline, Paroxetine | Depression, anxiety |
| Antipsychotics | Quetiapine, Clozapine | Schizophrenia, bipolar disorder |
| Antihistamines | Diphenhydramine (Benadryl) | Allergies, sleep aids |
| Parkinson’s medications | Trihexyphenidyl, Benztropine | Tremors, muscle stiffness |
| Anti-nausea medications | Meclizine, Promethazine | Motion sickness, nausea |
What the Research Shows
| Study Finding | Implication |
|---|---|
| A Japanese study found oxybutynin (OR 4.53) and tolterodine (OR 5.64) significantly increased risk | Drug-specific risk; not all anticholinergics carry the same danger |
| A meta-analysis confirms the overall class association | Long-term anticholinergic use is linked to higher dementia risk |
| Risk appears to be dose- and duration-dependent | Higher cumulative use = greater risk |
